BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19493)

  • 1. Guide to urine testing in drug abuse prevention and multi-modality treatment programs.
    Kaistha KK
    J Chromatogr; 1977 Aug; 141(2):145-96. PubMed ID: 19493
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary screening for drugs in a hospital for the mentally subnormal.
    Ballinger BR; Simpson E; Stewart MJ
    Acta Psychiatr Scand; 1974; 50(6):619-24. PubMed ID: 4156151
    [No Abstract]   [Full Text] [Related]  

  • 3. Patterns of drug use by participants in the Western Australian methadone program, 1984-1991.
    Swensen G; Ilett KF; Dusci LJ; Hackett LP; Ong RT; Quigley AJ; Lenton S; Saker R; Caporn J
    Med J Aust; 1993 Sep; 159(6):373-6. PubMed ID: 8104312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thin-layer detection of pentazocine, tripelennamine, phencyclidine and propoxyphene alone or in combination with opiates in drug abuse urine screening programs.
    Kaistha KK; Tadrus R
    J Chromatogr; 1978 Aug; 155(1):214-7. PubMed ID: 28334
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
    Labat L; Fontaine B; Delzenne C; Doublet A; Marek MC; Tellier D; Tonneau M; Lhermitte M; Frimat P
    Forensic Sci Int; 2008 Jan; 174(2-3):90-4. PubMed ID: 17418990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods of identification and confirmation of abusive drugs in human urine.
    Roerig DL; Lewand D; Mueller M; Wang RI
    J Chromatogr; 1975 Jul; 110(2):349-59. PubMed ID: 1150842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLC techniques for identification of narcotics, barbiturates, and CNS stimulants in a drug abuse urine screening program.
    Kaistha KK; Jaffe JH
    J Pharm Sci; 1972 May; 61(5):679-89. PubMed ID: 5064346
    [No Abstract]   [Full Text] [Related]  

  • 8. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine identification of drugs of abuse in human urine. I. Application of fluorometry, thin-layer and gas-liquid chromatography.
    Mulé SJ
    J Chromatogr; 1971 Mar; 55(2):255-66. PubMed ID: 5547797
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of immunoassay methods for detection, in urine, of drugs subject to abuse.
    Mulé SJ; Bastos ML; Jukofsky D
    Clin Chem; 1974 Feb; 20(2):243-8. PubMed ID: 4130418
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methodology and problems in the study of drugs of abuse in urine].
    Sieghart W
    Wien Klin Wochenschr; 1986 Jun; 98(13):411-6. PubMed ID: 2875564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of drugs in urine for methadone treatment programs.
    Baselt RC; Casarett LJ
    J Chromatogr; 1971 Apr; 57(1):139-41. PubMed ID: 5103555
    [No Abstract]   [Full Text] [Related]  

  • 13. First analytical chemistry study on drug abuse in the Buenos Aires (Argentina) University students.
    Quiroga PN; Panzuto RI; Alvarez GB; Mirson DJ; Ochoa CF; Assem EM; López CM; Schkolnik LC; Villaamil EC; Roses OE
    Farmaco; 1998 Jun; 53(6):389-94. PubMed ID: 9764470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thin-layer chromatographic detection of barbiturates, narcotics, and amphetamines in urine of patients receiving psychotropic drugs.
    Heaton AM; Blumberg AG
    J Chromatogr; 1969 May; 41(3):367-70. PubMed ID: 5796330
    [No Abstract]   [Full Text] [Related]  

  • 15. Sweat testing in opioid users with a sweat patch.
    Kintz P; Tracqui A; Mangin P; Edel Y
    J Anal Toxicol; 1996 Oct; 20(6):393-7. PubMed ID: 8889674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs.
    Musshoff F; Trafkowski J; Lichtermann D; Madea B
    Int J Legal Med; 2010 Sep; 124(5):499-503. PubMed ID: 19672612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmed identification of biotransformed drugs of abuse in urine.
    Baden MM; Valanju NN; Verma SK; Valanju SN
    Am J Clin Pathol; 1972 Jan; 57(1):43-51. PubMed ID: 5008893
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of drug abuse by health professionals.
    Meeker JE; Mount AM; Ross W
    J Healthc Prot Manage; 2003; 19(1):73-81. PubMed ID: 12629790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of a toxicology laboratory facility. Development expenses and cost per urine test using thin layer chromatographic techniques in a drug abuse urine screening program.
    Kaistha KK; Jaffe JH
    Int J Addict; 1972; 7(3):585-92. PubMed ID: 5085286
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug abuse patterns of patients on methadone treatment in New York City.
    Kaul B; Davidow B
    Am J Drug Alcohol Abuse; 1981; 8(1):17-25. PubMed ID: 7304510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.